0
     

Report Added
Report already added
Rx/Reimbursement Adult Incontinence in Serbia

Rx/Reimbursement Adult Incontinence in Serbia

In similar trends noted in most retail hygiene products, rx/reimbursement adult incontinence in Serbia was completely unaffected by the emergence of COVID-19. This was because the category remained untouched by the pandemic in 2020, and therefore, there was no bounce back from declines the following year. Those who are eligible to receive rx/reimbursement adult incontinence products can access them from chemists/pharmacies, regarded as an essential service during the pandemic, with this channel...

Euromonitor International's Rx/Reimbursement adult incontinence in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2026 illustrate how the market is set to change.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Rx/Reimbursement Adult Incontinence in Serbia

List Of Contents And Tables

RX/REIMBURSEMENT ADULT INCONTINENCE IN SERBIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Demand for rx/reimbursement adult incontinence remains unaffected by pandemic
No changes to legislation and eligibility
Ageing population supports increasing demand, gaining share from retail products
PROSPECTS AND OPPORTUNITIES
Further ageing of population to support stronger demand over the forecast period
Changes to legislation unlikely, but list of eligible recipients could expand
Rising average unit to drive up higher value growth than volume
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2016-2021
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2016-2021
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2021-2026
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2021-2026
TISSUE AND HYGIENE IN SERBIA
EXECUTIVE SUMMARY
Tissue and hygiene in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2016-2021
Table 6 Infant Population 2016-2021
Table 7 Female Population by Age 2016-2021
Table 8 Total Population by Age 2016-2021
Table 9 Households 2016-2021
Table 10 Forecast Infant Population 2021-2026
Table 11 Forecast Female Population by Age 2021-2026
Table 12 Forecast Total Population by Age 2021-2026
Table 13 Forecast Households 2021-2026
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2016-2021
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2016-2021
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2017-2021
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2018-2021
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2016-2021
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2016-2021
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2021
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2021-2026
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2021-2026
DISCLAIMER
SOURCES
Summary 1 Research Sources

Report Title: Rx/Reimbursement Adult Incontinence in Serbia


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW